Ingevity (NYSE: NGVT) reported Q1 EPS of $1.09, $0.05 worse than the analyst estimate of $1.14. Revenue for the quarter came in at $392.6 million versus the consensus estimate of $413.72 million.

GUIDANCE:

Ingevity sees FY2023 revenue of $1.75-1.95 billion, versus the consensus of $1.92 billion.

For earnings history and earnings-related data on Ingevity (NGVT) click here.